Detalhe da pesquisa
1.
Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma.
Transfus Apher Sci
; 62(3): 103638, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610860
2.
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial.
J Infect Chemother
; 29(9): 869-874, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178973
3.
How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
Transfusion
; 61(7): 1998-2007, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096059
4.
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals.
Life (Basel)
; 13(11)2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38004324
5.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.
Heliyon
; 9(10): e20568, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842585
6.
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
Life (Basel)
; 12(6)2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743887
7.
Enhancing the blood safety program in Myanmar: Report on projects of global extension of medical technologies of Japan.
Glob Health Med
; 3(1): 48-51, 2021 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688596